NL
 

Harm reduction for stimulant users

A MAINLINE-GIZ STUDY

With the support of the Global Partnership on Drug Policies and Development (GPDPD), a project implemented by Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH, a team of three Mainline researchers conducted a study into effective harm reduction interventions for stimulant users. The study includes a review of the evidence for different harm reduction strategies for stimulants and a detailed description of seven good practices in different world regions.  

The need

As most harm reduction interventions are funded under the umbrella of HIV, most of the research and project funding also goes to analyse the effectiveness of HIV/AIDS strategies. This means that both programmes and the evidence focus on those drug users who inject their drug and they leave out those who smoke, snort or swallow. The people who can benefit from harm reduction interventions are most often injecting opioid users, and harm reduction often becomes associated with heroin use alone. At the same time, people using stimulants may face somewhat different problems, regarding health as well as psychosocial and legal circumstances. As this leaves many marginalised stimulant users underserviced, there is a need for the harm reduction field to broaden the scope and to structurally include stimulant users.






Rafaela Rigoni


What we know

The body of available research conducted on effective harm reduction for stimulant users provides some basic insights. We understand the chemical structures of stimulants and how they stimulate the central nervous system. We can categorise stimulants into cocaine, amphetamines, meth-amphetamines, methcathinones and cathinones. There is abundant information about the attributes and effects of stimulants:

They increase wakefulness, focus and confidence; they can elevate someone’s mood and provide feelings of power; they decrease fatigue and appetite. They can also produce nervousness or anxiety and, in some cases, psychosis and suicidal thoughts (e.g. Holman, 1994; EMCDDA, 2007; Hildrey et al., 2009; Pates and Riley, 2009).

What we don’t know enough yet is which harm reduction strategies have been developed worldwide for different contexts and types of stimulants user, and which of those strategies are being positively evaluated. The harm reduction field would greatly benefit from more practical guidance to establish interventions for stimulant users in specific contexts. This study aims to fill that need.







Research team


Joost Breeksema


What we study

The present study:

  • Performs a systematic and worldwide literature review of harm reduction activities for stimulant drugs;
  • Documents, describes and analyses 8 cases of best practices of harm reduction for stimulant users in different world regions;
  • Contributes to normative guidance in supporting harm reduction for stimulant users by disseminating study results in an attractive and comprehensive format;
  • Stimulates a harm reduction narrative which moves beyond HIV and focuses on human rights and improved quality of life for those who use stimulants.

Implementation of the research started on 1 September 2017 and was finalised in August 2018.

Here you can find the final report and the executive summary.

View the final presentation.

Contact (lead researcher): Rafaela de Quadros Rigoni: r.rigoni@mainline.nl

Project News






Sara Woods

Our current projects


internationaal

Love Alliance

Burkina Faso, Burundi, Egypt, Kenya, Marocco, Mozambique, Nigeria, South Africa, Uganda, Zimbabwe

Mainline is a partner in the Love Alliance programme. The Love Alliance brings together organisations led by communities most affected by HIV and AIDS.

> Read more
internationaal

Gender-based violence

Kenya

Women who use drugs in Kenya face violence every day. At home. On the streets. By the police. In their communities. A unique study - conducted in Mombasa, Kenya - sheds light on the tough realities these women encounter. Urgent action is needed now.

> Read more
internationaal

Women Who Use Drugs & Peer Workers

South Africa

Women Who Use Drugs face additional problems compared to their male counterparts. The harm reduction field far too often neglects the needs of women. To some extent, the same is true for peer workers: incredibly valuable staff in any impactful service. How can local services make sure that peer workers are valued, supported and living up to their full potential?

> Read more

Train-the-trainer programme

In 2017, Mainline launched its first international train-the-trainer (ToT) programme. The objective of the programme is to develop the in-house training capacity of local partner organisations, making Mainlines capacity building efforts more sustainable in the long term.

> Read more

Mainline - Technical Advice

Did Mainline become a supplier? Yes: a supplier of technical advice for the Global Fund. Harm reduction organisations and networks of people who use drugs across the world can now request a Mainline training or capacity building. Read more about how this works.

> Read more
internationaal

Mindful Muscles

United Kingdom, Finland, Greece, Estonia, Serbia, Portugal, the Netherlands

Harm reduction approaches are rarely applied in a recreational sports setting. And why would we - sport equals health, right? Not always. Research shows that the use of performance and image-enhancing drugs (PIEDs) is quite common in various recreational sport scenes. And for those people who use frequently and in high doses, harm reduction can make a big difference.

> Read more
internationaal

Young, Wild and... Free?

Kenya, South Africa

Young people use drugs - including minors. It's an inconvenient truth: societies usually seek to prevent young people from damaging their health and there is a big taboo on drug use among young kids. But are stigma, legislation or moral judgement keeping young people away from harm reduction services? This project aims to find and improve access to services.

> Read more
internationaal

Chemsex

Global

The use of drugs during sex is a growing worldwide phenomenon among men who have sex with men (MSM). Mainline has built a unique track record while working in the frontline of the Dutch 'chemsex' scene. Now, we also apply this expertise in an international context. The best place to start? Our chemsex e-learning.  

> Read more
internationaal

Quality Harm Reduction

Iran

Iran is renowned for its harm reduction programme. It was one of the first countries in this geographical region to adopt a harm reduction approach. Government supports and funds the programme. But the drug scene in Iran has changed over the past 20 years. More people are using stimulant drugs and, due to economic circumstances, more people who use drugs have become homeless. Mainline sets out to see whether the current programme in Tehran still fits the needs of the local people who use drugs.

> Read more
internationaal

Prison Health

Indonesia

Prisons in Indonesia are often overcrowded and health services are limited. Is quality prison health too expensive? Not according to findings from Atma Jaya University, who applied the method of 'economic modelling' to prison health services, including drug dependency programmes. The findings feed important advocacy messages to improve the prison system in 2021.

> Read more
internationaal

Hanoi field lab for stimulant harm reduction

Vietnam

October 2019 marked the start of a cutting edge new initiative. With the support of Open Society Foundation, Mainline and SCDI in Vietnam are building expertise to support people who use stimulant drugs. The core motivation to do so is the sharp rise in the use of crystal meth in the South Asian region and the lack of a coordinated harm reduction response.

> Read more

Our finished projects

internationaal

Reducing harms in the work environment

South Africa

Together with activists and peer- and outreach workers in South Africa, Mainline worked on a practical guide about involving peers in harm reduction work.

> Read more

Harm reduction for stimulant users

A MAINLINE-GIZ STUDY

With the support of the Global Partnership on Drug Policies and Development (GPDPD), a project implemented by Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH, a team of three Mainline researchers conducted a study into effective harm reduction interventions for stimulant users. The study includes a review of the evidence for different harm reduction strategies for stimulants and a detailed description of seven good practices in different world regions.  

> Read more
internationaal

Bridging the Gaps 2: 2016 - 2020

Indonesia, Kenya, Nepal, Pakistan, South Africa, Tanzania and Vietnam

The Bridging the Gaps programme started its second phase in January 2016 and continued until the end of 2020. The shared goal of the Bridging the Gaps alliance: to improve the health and rights of people who use drugs, sex workers and lesbian, gay, bisexual and transgender (LGBT) people.

> Read more
internationaal

Tanzania

Heroin use has increased enormously in Tanzania and other East African countries in recent years. East Africa is situated along the heroin trafficking routes from Afghanistan to Western Europe, and this has also affected local consumption. It is estimated that there are 30,000 people who inject heroin in Tanzania wherein at least 10,000 of them live in the capital Dar es Salaam. People who use drugs in Tanzania are marginalised and cope with infectious diseases, overdose and police brutality. In 2019, Mainline partnered with Mukikute to build better health services for this vulnerable group of people.

> Read more

Multi-country study on harm reduction and community involvement

Funded by Bridging the Gaps, this study aimed to understand how involvement of people who use drugs can influence the quality and availability of harm reduction services. The study took place in three countries - Indonesia, Kyrgyzstan and South Africa.

> Read more

Vietnam

In the last decade, the use of methamphetamine – also referred to as ‘meth’ or ‘ice’ – has increased significantly throughout Southeast Asia. And Vietnam is not an exception.

> Read more
Copyright Mainline 2021. Webdesign by Studio Odilo Girod, hosting & CMS by Blogbird.